Home Emergency department triage of patients with acute chest pain: definition of cardiac troponin I decisional value to manage patients without electrocardiographic evidence of ischemia
Article
Licensed
Unlicensed Requires Authentication

Emergency department triage of patients with acute chest pain: definition of cardiac troponin I decisional value to manage patients without electrocardiographic evidence of ischemia

  • Pascale Beyne , Erik Bouvier , Patrick Werner , Pierre Bourgoin , Damien Logeart , Laurent Alliot , Habiba Daïkha and Michel Vidaud
Published/Copyright: June 1, 2005

Abstract

The aim of this study was to define the use of a new cardiac troponin I (cTnI) assay for emergency patients with chest pain and no specific electrocardiographic changes consistent with the presence of ischemia. Patients (n=106) admitted in Emergency/Cardiology Departments for chest pain and suspicion of acute coronary syndrome (ACS) were randomized into two diagnosis groups (ACS or non-ACS) by two independent cardiologists. cTnI measurements were performed at admission, and 6 hours and 12 hours later with a new generation assay (Access AccuTnI, Beckman Coulter). Using an upper reference limit of 0.04 μg/l, 27 patients had a cTnI elevation not related to the final diagnosis of ischemia; the positive predictive value (PPV) was 67% with specificity 48%. The decisional value was re-defined and set at 0.16 μg/l, a concentration corresponding to the 99th percentile of the non-ACS patient group. Precision (coefficient of variation) was 8% at this level, PPV 97% and specificity 98%. This new decisional value is now used in our institution and could be included in standard care guidelines to improve the management of patients presenting chest pain in emergency departments.

Published Online: 2005-6-1
Published in Print: 2004-5-10

Copyright © 2004 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Beyond cholesterol - inflammatory cytokines, the key mediators in atherosclerosis
  2. The emerging value of P-selectin as a disease marker
  3. Analysis of candidate genes in Polish families with obesity
  4. Detection of the Arg702Trp, Gly908Arg and Leu1007fsinsC polymorphisms of the NOD2/CARD15 gene by real-time PCR with melting curve analysis
  5. Up-regulation of reactive oxygen species (ROS) and resistance to Fas-mediated apoptosis in the C33A cervical cancer cell line transfected with IL-18 receptor
  6. Rapid detection of mutations in Wilson disease gene ATP7B by DNA strip technology
  7. Moderate exercise with a dietary vitamin C and E combination protects against streptozotocin-induced oxidative damage to the blood and improves fetal outcomes in pregnant rats
  8. Plasma levels of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amino-thiols as discriminatory tools of Alzheimer's disease and vascular dementia
  9. Abnormalities in apolipoprotein and lipid levels in an HIV-infected Brazilian population under different treatment profiles: the relevance of apolipoprotein E genotypes and immunological status
  10. An International Standard for whole blood folate: evaluation of a lyophilised haemolysate in an international collaborative study
  11. Population-specific reference values for thyroid hormones on the Abbott ARCHITECT i2000 analyzer
  12. Amphetamines and 3,4-methylendioxymetamphetamine (MDMA): evaluation of KIMS (kinetic interaction of microparticles in solution) assay at two cut-off levels
  13. Comparison of sensitivity and specificity of serum poly-C avid ribonuclease activity and C-reactive protein concentration in detection of mild and severe acute pancreatitis
  14. Emergency department triage of patients with acute chest pain: definition of cardiac troponin I decisional value to manage patients without electrocardiographic evidence of ischemia
  15. Genetic analysis of glutathione S-transferase A1 and T1 polymorphisms in a Japanese population
  16. The European Register for Specialists in Clinical Chemistry and Laboratory Medicine: Code ofConduct
  17. Decision cut-off of the polyethylene glycol precipitation technique in screening for macroprolactinemia on Immulite 2000
  18. No bias between the first and the new version of RIA for serum holo-transcobalamin by Axis-Shield
  19. Meetings and Awards
  20. SIBioC 2004: 36th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Padua, Italy, 8-11 June 2004
Downloaded on 13.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2004.094/html
Scroll to top button